Project PHOENIX: Molecular Signatures of Burn Pit Exposure
1,000 participantsStarted 2026-05-01
Plain-language summary
Project PHOENIX is an observational clinical research study designed to characterize molecular, genomic, cellular, and functional features in blood specimens from former U.S. Service Members with prior burn pit exposure and from matched unexposed controls. Participants will complete screening, informed consent, health and exposure questionnaires, and a one-time blood collection. Blood-derived specimens may undergo genomic, epigenomic, transcriptomic, proteomic, metabolomic, immunophenotyping, and cellular functional analyses. Participants may also agree to optional future re-contact for health updates and possible repeat blood collection. The goal is to identify biologic signatures associated with prior deployment-related burn pit exposure and to support future biomarker discovery and translational research in veteran health.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 18 years or older at the time of consent
* Former or current U.S. Service Member, including Active Duty, Reserve, National Guard, or Veteran status
* For exposed cohort: prior deployment to a location with known burn pit operations, based on participant report and available confirmation when feasible
* For control cohort: no known deployment to burn pit locations
* Able and willing to provide informed consent and HIPAA authorization
* Willing to complete study questionnaires and donate venous blood sample
* Able to complete study procedures in English or with approved translation support
* Available for one baseline visit and optional future re-contact, if applicable
Exclusion Criteria:
* Active serious illness or infection that, in the investigator's judgment, would compromise participation or specimen integrity
* Receipt of systemic chemotherapy, immunotherapy, or radiation therapy within the past 6 months
* High-dose systemic immunosuppression, defined as more than 20 mg prednisone equivalent daily for more than 14 days within the past 3 months
* Pregnant or currently breast-feeding
* Hemoglobin less than 10 g/dL, known bleeding disorder, or platelet count less than 100 × 10\^9/L, if known
* Severe psychiatric illness or other condition that impairs ability to provide informed consent
* Prisoner or institutionalized individual
* Prior participation in this or a related Project PHOENIX protocol
* Any other condition that, in the investigator's j…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Differential gene expression (RNA-seq normalized counts) between burn pit-exposed and unexposed cohorts